Ching Ming, Maxey Chung

Chung Ching Ming, Maxey

  • Associate Professor, Department of Biochemistry
Administrative Appointment(s)
  • Deputy Head, Department of Biochemistry
  • President, Asia Ocean Human proteome Organisation
Academic Qualifications
  • PhD, Victoria University of Wellington, New Zealand
  • MSc (Hons, First Class), Victoria University Of Wellington, New Zealand
  • BSc, Victoria University of Wellington, New Zealand
Research Interest(s)
  • Proteomics
  • Liver
  • Gastric and Colorectal Cancers
  • Biomarkers Discovery
  • Protein Structure and Function
Recent Publications
  • 1. Wu W, Yong WW, Chung MCM. 2016 Nov. A simple biomarker scoring matrix for early gastric cancer detection. Proteomics. 16(22):2921-2930. doi: 10.1002/pmic.201600194.
  • 2. Lin Q, Lim HS, Lin HL, Tan HT, Lim TK, Cheong WK3, Cheah PY, Tang CL, Chow PK, Chung MC. 2015 Nov. Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer. Proteomics. 15(22):3905-20. doi: 10.1002/pmic.201500236.
  • 3. Tan HT, Lim TK, Richards AM, Kofidis T, Teoh KL, Ling LH, Chung MC. 2015 Sep. Unravelling the proteome of degenerative human mitral valves. Proteomics. 15(17):2934-44. doi: 10.1002/pmic.201500040.
  • 4. Ong CW, Chong PY, McArt DG, Chan JY, Tan HT, Kumar AP, Chung MC, Clément MV, Soong R, Van Schaeybroeck S, Waugh DJ, Johnston PG, Dunne PD, Salto-Tellez M. 2015 May. The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers. Oncotarget. 6(14):12763-73. doi: 10.18632/oncotarget.3497.
  • 5. Wu W, Tan XF, Tan HT, Lim TK, Chung MC. 2014 Dec. Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment. Mol Cancer Res. 12(12):1717-28. doi: 10.1158/1541-7786.MCR-14-0088-T.